Differential Uridyl-diphosphate-Glucuronosyl Transferase 1A enzymatic arsenal explains the specific cytotoxicity of resveratrol towards tumor colorectal cells

Resveratrol belongs to the Bioactive Food Component (BFC) family. It seems admitted that its cytotoxic action impacts tumor cells and spares healthy cells, but the published proofs remain rare. We hypothesized that cells may differentially metabolize resveratrol and lead to different systemic impact...

Full description

Bibliographic Details
Main Authors: Samuel Amintas, Pauline Beaumont, Charles Dupin, Isabelle Moranvillier, Isabelle Lamrissi, Elie Patel, Benjamin Fernandez, Alice Bibeyran, Julian Boutin, Tristan Richard, Stéphanie Krisa, François Moreau-Gaudry, Aurélie Bedel, David Cappellen, Benoît Pinson, Véronique Vendrely, Sandrine Dabernat
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:Journal of Functional Foods
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1756464622004157
_version_ 1811187596955484160
author Samuel Amintas
Pauline Beaumont
Charles Dupin
Isabelle Moranvillier
Isabelle Lamrissi
Elie Patel
Benjamin Fernandez
Alice Bibeyran
Julian Boutin
Tristan Richard
Stéphanie Krisa
François Moreau-Gaudry
Aurélie Bedel
David Cappellen
Benoît Pinson
Véronique Vendrely
Sandrine Dabernat
author_facet Samuel Amintas
Pauline Beaumont
Charles Dupin
Isabelle Moranvillier
Isabelle Lamrissi
Elie Patel
Benjamin Fernandez
Alice Bibeyran
Julian Boutin
Tristan Richard
Stéphanie Krisa
François Moreau-Gaudry
Aurélie Bedel
David Cappellen
Benoît Pinson
Véronique Vendrely
Sandrine Dabernat
author_sort Samuel Amintas
collection DOAJ
description Resveratrol belongs to the Bioactive Food Component (BFC) family. It seems admitted that its cytotoxic action impacts tumor cells and spares healthy cells, but the published proofs remain rare. We hypothesized that cells may differentially metabolize resveratrol and lead to different systemic impacts. For this, resveratrol metabolization was evaluated by ultra-high-performance liquid chromatography (UHPLC) coupled with diode array detection (DAD), and correlated with the expression of Uridyl-diphosphate-Glucuronosyl Transferase 1A (UGT1A) genes. The expression of UGT1A genes in human colorectal tissues was studied with RNAseq databases. Functional validation of UGT1A enzymes implication in resveratrol sensitivity of colorectal cells established by UGT1A expression modulation. As resveratrol impacts the S phase of the cell cycle, nucleotide metabolic balance was assessed. We found that resveratrol was more cytotoxic in cells with downregulation of UGTs, i.e. tumor cells. Conversely, overexpression of the UGT1A10 gene in an initial resveratrol-sensitive tumor cell line restored the metabolization accompanied by cytotoxicity diminution. Resveratrol affected intestinal sensitive tumor cell homeostasis with a cell growth/proliferation decoupling, cell-cycle modulation, and UXP/AXP nucleotide imbalance resulting in a global reduction of transcription and translation. This impact on global cell activity was restricted to tumor cells. This study improves resveratrol’s general knowledge and explains how its antitumor action can spare non-tumor cells. It also paves the way to select colorectal tumors eligible for resveratrol treatment potentiation without additional toxicity to healthy digestive tissues.
first_indexed 2024-04-11T14:06:07Z
format Article
id doaj.art-a6b60731bfbd48399c87283fc03376bc
institution Directory Open Access Journal
issn 1756-4646
language English
last_indexed 2024-04-11T14:06:07Z
publishDate 2022-12-01
publisher Elsevier
record_format Article
series Journal of Functional Foods
spelling doaj.art-a6b60731bfbd48399c87283fc03376bc2022-12-22T04:19:53ZengElsevierJournal of Functional Foods1756-46462022-12-0199105345Differential Uridyl-diphosphate-Glucuronosyl Transferase 1A enzymatic arsenal explains the specific cytotoxicity of resveratrol towards tumor colorectal cellsSamuel Amintas0Pauline Beaumont1Charles Dupin2Isabelle Moranvillier3Isabelle Lamrissi4Elie Patel5Benjamin Fernandez6Alice Bibeyran7Julian Boutin8Tristan Richard9Stéphanie Krisa10François Moreau-Gaudry11Aurélie Bedel12David Cappellen13Benoît Pinson14Véronique Vendrely15Sandrine Dabernat16BoRdeaux institute In onCology – BRIC U1312, INSERM, Univ. Bordeaux, CHU de Bordeaux, Service de biologie des tumeurs et Tumorothèque, Bordeaux, FranceUR Oenologie, EA 4577, USC 1366 INRAE, INP, ISVV, Univ. Bordeaux, Villenave d'Ornon, FranceBoRdeaux institute In onCology – BRIC U1312, INSERM, Univ. Bordeaux, CHU de Bordeaux, Service de Radiothérapie, Bordeaux, FranceBoRdeaux institute In onCology – BRIC U1312, INSERM, Univ. Bordeaux, Bordeaux, FranceBoRdeaux institute In onCology – BRIC U1312, INSERM, Univ. Bordeaux, Bordeaux, FranceBoRdeaux institute In onCology – BRIC U1312, INSERM, Univ. Bordeaux, Bordeaux, FranceBoRdeaux institute In onCology – BRIC U1312, INSERM, Univ. Bordeaux, CHU de Bordeaux, Service de chirurgie digestive, Bordeaux, FrancePlateforme Vect’UB, TBMcore - Univ. Bordeaux, Bordeaux, FranceBoRdeaux institute In onCology – BRIC U1312, INSERM, Univ. Bordeaux, CHU de Bordeaux, Service de Biochimie et Biologie moléculaire, Bordeaux, FranceUR Oenologie, EA 4577, USC 1366 INRAE, INP, ISVV, Univ. Bordeaux, Villenave d'Ornon, FranceUR Oenologie, EA 4577, USC 1366 INRAE, INP, ISVV, Univ. Bordeaux, Villenave d'Ornon, FranceBoRdeaux institute In onCology – BRIC U1312, INSERM, Univ. Bordeaux, CHU de Bordeaux, Service de Biochimie et Biologie moléculaire, Bordeaux, FranceBoRdeaux institute In onCology – BRIC U1312, INSERM, Univ. Bordeaux, CHU de Bordeaux, Service de Biochimie et Biologie moléculaire, Bordeaux, FranceBoRdeaux institute In onCology – BRIC U1312, INSERM, Univ. Bordeaux, CHU de Bordeaux, Service de biologie des tumeurs et Tumorothèque, Bordeaux, FranceUMR 5095, CNRS, Institut de Biochimie et Génétique Cellulaires, 33077 Bordeaux, France; Service Analyses Métabolique, TBMcore - Univ. Bordeaux - CNRS UAR 3427 - INSERM US005, FranceBoRdeaux institute In onCology – BRIC U1312, INSERM, Univ. Bordeaux, CHU de Bordeaux, Service de Radiothérapie, Bordeaux, FranceBoRdeaux institute In onCology – BRIC U1312, INSERM, Univ. Bordeaux, CHU de Bordeaux, Service de Biochimie et Biologie moléculaire, Bordeaux, France; Corresponding author at: Université de Bordeaux, INSERM U1312, Bordeaux Institute of Oncology (BRIC), 146, Rue Léo Saignat, 33076 Bordeaux Cedex, France.Resveratrol belongs to the Bioactive Food Component (BFC) family. It seems admitted that its cytotoxic action impacts tumor cells and spares healthy cells, but the published proofs remain rare. We hypothesized that cells may differentially metabolize resveratrol and lead to different systemic impacts. For this, resveratrol metabolization was evaluated by ultra-high-performance liquid chromatography (UHPLC) coupled with diode array detection (DAD), and correlated with the expression of Uridyl-diphosphate-Glucuronosyl Transferase 1A (UGT1A) genes. The expression of UGT1A genes in human colorectal tissues was studied with RNAseq databases. Functional validation of UGT1A enzymes implication in resveratrol sensitivity of colorectal cells established by UGT1A expression modulation. As resveratrol impacts the S phase of the cell cycle, nucleotide metabolic balance was assessed. We found that resveratrol was more cytotoxic in cells with downregulation of UGTs, i.e. tumor cells. Conversely, overexpression of the UGT1A10 gene in an initial resveratrol-sensitive tumor cell line restored the metabolization accompanied by cytotoxicity diminution. Resveratrol affected intestinal sensitive tumor cell homeostasis with a cell growth/proliferation decoupling, cell-cycle modulation, and UXP/AXP nucleotide imbalance resulting in a global reduction of transcription and translation. This impact on global cell activity was restricted to tumor cells. This study improves resveratrol’s general knowledge and explains how its antitumor action can spare non-tumor cells. It also paves the way to select colorectal tumors eligible for resveratrol treatment potentiation without additional toxicity to healthy digestive tissues.http://www.sciencedirect.com/science/article/pii/S1756464622004157Bioactive food componentsUGTDrug sensitivityColorectal cancerTumorigenesisNucleotide metabolism
spellingShingle Samuel Amintas
Pauline Beaumont
Charles Dupin
Isabelle Moranvillier
Isabelle Lamrissi
Elie Patel
Benjamin Fernandez
Alice Bibeyran
Julian Boutin
Tristan Richard
Stéphanie Krisa
François Moreau-Gaudry
Aurélie Bedel
David Cappellen
Benoît Pinson
Véronique Vendrely
Sandrine Dabernat
Differential Uridyl-diphosphate-Glucuronosyl Transferase 1A enzymatic arsenal explains the specific cytotoxicity of resveratrol towards tumor colorectal cells
Journal of Functional Foods
Bioactive food components
UGT
Drug sensitivity
Colorectal cancer
Tumorigenesis
Nucleotide metabolism
title Differential Uridyl-diphosphate-Glucuronosyl Transferase 1A enzymatic arsenal explains the specific cytotoxicity of resveratrol towards tumor colorectal cells
title_full Differential Uridyl-diphosphate-Glucuronosyl Transferase 1A enzymatic arsenal explains the specific cytotoxicity of resveratrol towards tumor colorectal cells
title_fullStr Differential Uridyl-diphosphate-Glucuronosyl Transferase 1A enzymatic arsenal explains the specific cytotoxicity of resveratrol towards tumor colorectal cells
title_full_unstemmed Differential Uridyl-diphosphate-Glucuronosyl Transferase 1A enzymatic arsenal explains the specific cytotoxicity of resveratrol towards tumor colorectal cells
title_short Differential Uridyl-diphosphate-Glucuronosyl Transferase 1A enzymatic arsenal explains the specific cytotoxicity of resveratrol towards tumor colorectal cells
title_sort differential uridyl diphosphate glucuronosyl transferase 1a enzymatic arsenal explains the specific cytotoxicity of resveratrol towards tumor colorectal cells
topic Bioactive food components
UGT
Drug sensitivity
Colorectal cancer
Tumorigenesis
Nucleotide metabolism
url http://www.sciencedirect.com/science/article/pii/S1756464622004157
work_keys_str_mv AT samuelamintas differentialuridyldiphosphateglucuronosyltransferase1aenzymaticarsenalexplainsthespecificcytotoxicityofresveratroltowardstumorcolorectalcells
AT paulinebeaumont differentialuridyldiphosphateglucuronosyltransferase1aenzymaticarsenalexplainsthespecificcytotoxicityofresveratroltowardstumorcolorectalcells
AT charlesdupin differentialuridyldiphosphateglucuronosyltransferase1aenzymaticarsenalexplainsthespecificcytotoxicityofresveratroltowardstumorcolorectalcells
AT isabellemoranvillier differentialuridyldiphosphateglucuronosyltransferase1aenzymaticarsenalexplainsthespecificcytotoxicityofresveratroltowardstumorcolorectalcells
AT isabellelamrissi differentialuridyldiphosphateglucuronosyltransferase1aenzymaticarsenalexplainsthespecificcytotoxicityofresveratroltowardstumorcolorectalcells
AT eliepatel differentialuridyldiphosphateglucuronosyltransferase1aenzymaticarsenalexplainsthespecificcytotoxicityofresveratroltowardstumorcolorectalcells
AT benjaminfernandez differentialuridyldiphosphateglucuronosyltransferase1aenzymaticarsenalexplainsthespecificcytotoxicityofresveratroltowardstumorcolorectalcells
AT alicebibeyran differentialuridyldiphosphateglucuronosyltransferase1aenzymaticarsenalexplainsthespecificcytotoxicityofresveratroltowardstumorcolorectalcells
AT julianboutin differentialuridyldiphosphateglucuronosyltransferase1aenzymaticarsenalexplainsthespecificcytotoxicityofresveratroltowardstumorcolorectalcells
AT tristanrichard differentialuridyldiphosphateglucuronosyltransferase1aenzymaticarsenalexplainsthespecificcytotoxicityofresveratroltowardstumorcolorectalcells
AT stephaniekrisa differentialuridyldiphosphateglucuronosyltransferase1aenzymaticarsenalexplainsthespecificcytotoxicityofresveratroltowardstumorcolorectalcells
AT francoismoreaugaudry differentialuridyldiphosphateglucuronosyltransferase1aenzymaticarsenalexplainsthespecificcytotoxicityofresveratroltowardstumorcolorectalcells
AT aureliebedel differentialuridyldiphosphateglucuronosyltransferase1aenzymaticarsenalexplainsthespecificcytotoxicityofresveratroltowardstumorcolorectalcells
AT davidcappellen differentialuridyldiphosphateglucuronosyltransferase1aenzymaticarsenalexplainsthespecificcytotoxicityofresveratroltowardstumorcolorectalcells
AT benoitpinson differentialuridyldiphosphateglucuronosyltransferase1aenzymaticarsenalexplainsthespecificcytotoxicityofresveratroltowardstumorcolorectalcells
AT veroniquevendrely differentialuridyldiphosphateglucuronosyltransferase1aenzymaticarsenalexplainsthespecificcytotoxicityofresveratroltowardstumorcolorectalcells
AT sandrinedabernat differentialuridyldiphosphateglucuronosyltransferase1aenzymaticarsenalexplainsthespecificcytotoxicityofresveratroltowardstumorcolorectalcells